Tirzepatide, on the other hand, benefits from a growing body of real-world evidence and clinician familiarity, which could sustain its dominance even as next-generation agents emerge
Further development and approvals: After the success of Exenatide, several other GLP-1 agonists were developed and approved for the treatment of type 2 diabetes
Consult a healthcare professional before use if pregnant, nursing, taking medication, or have a medical condition
All mechanistic interpretations remain observational and exploratory in nature and are confined exclusively to non-clinical research settings
Christine Graham Verified "I chose Mochi because I was tired of struggling alone and wanted real support, not just a prescription." Kristina Follis Verified These are real Mochi members who were compensated for sharing their experiences